| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Scholar Rock Holding Corp | Director | Common Stock | 15,057 | $451,756 | $30.00 | 29 May 2025 | Direct |
| Prime Medicine, Inc. | Chief Business Officer | Common Stock | 20,000 | $23,790 | $1.19 | 20 May 2025 | Direct |
| VOLITIONRX LTD | Director | Common Stock | 27,936 | $23,187 | $0.8300 | 12 Jan 2023 | Direct |
| Prime Medicine, Inc. | Chief Business Officer | Stock Option (right to buy) | 225,000 | 27 Feb 2025 | Direct | ||
| Codiak BioSciences, Inc. | Officer title: Chief Business Officer and Head of Corporate Strategy | Restricted Stock Units | 16,275 | 16 Feb 2022 | Direct | ||
| Codiak BioSciences, Inc. | Officer title: Chief Business Officer and Head of Corporate Strategy | Stock Option (Right to Buy) | 10,850 | 16 Feb 2022 | Direct | ||
| Scholar Rock Holding Corp | Director | Stock Option (Right to Buy) | 9,206 | 22 May 2025 | Direct | ||
| VOLITIONRX LTD | Director | Stock Option (Right to Buy) | 8,635 | 23 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SRRK | Scholar Rock Holding Corp | 29 May 2025 | 2 | -$180,531 | 4 | Director | 30 May 2025, 16:31 |
| SRRK | Scholar Rock Holding Corp | 22 May 2025 | 2 | $0 | 4 | Director | 23 May 2025, 16:47 |
| PRME | Prime Medicine, Inc. | 20 May 2025 | 1 | +$23,790 | 4 | Chief Business Officer | 22 May 2025, 16:22 |
| PRME | Prime Medicine, Inc. | 27 Feb 2025 | 1 | $0 | 4 | Chief Business Officer | 03 Mar 2025, 20:12 |
| PRME | Prime Medicine, Inc. | 05 Dec 2024 | 1 | $0 | 4 | Chief Business Officer | 09 Dec 2024, 18:22 |
| SRRK | Scholar Rock Holding Corp | 27 Jun 2024 | 2 | $0 | 4 | Director | 01 Jul 2024, 17:15 |
| PRME | Prime Medicine, Inc. | 17 May 2024 | 1 | $0 | 4 | Chief Business Officer | 21 May 2024, 16:11 |
| PRME | Prime Medicine, Inc. | 21 Feb 2024 | 1 | $0 | 4 | Chief Business Officer | 23 Feb 2024, 17:04 |
| SRRK | Scholar Rock Holding Corp | 06 Apr 2023 | 1 | $0 | 4 | Director | 10 Apr 2023, 16:31 |
| SRRK | Scholar Rock Holding Corp | 06 Apr 2023 | 0 | $0 | 3 | Director | 10 Apr 2023, 16:26 |
| PRME | Prime Medicine, Inc. | 31 Mar 2023 | 1 | $0 | 4 | Chief Business Officer | 04 Apr 2023, 20:22 |
| VNRX | VOLITIONRX LTD | 12 Jan 2023 | 1 | $0 | 4 | Director | 13 Jan 2023, 15:03 |
| PRME | Prime Medicine, Inc. | 19 Oct 2022 | 0 | $0 | 3 | Chief Business Officer | 19 Oct 2022, 20:05 |
| VNRX | VOLITIONRX LTD | 13 Oct 2022 | 1 | $0 | 4 | Director | 14 Oct 2022, 16:06 |
| VNRX | VOLITIONRX LTD | 23 Jun 2022 | 2 | $0 | 4 | Director | 24 Jun 2022, 16:05 |
| VNRX | VOLITIONRX LTD | 07 Apr 2022 | 2 | $0 | 4 | Director | 08 Apr 2022, 16:02 |
| /report/000089924322007015-brudnick-richard-2022-02-16 | Codiak BioSciences, Inc. | 16 Feb 2022 | 2 | $0 | 4 | Officer title: Chief Business Officer and Head of Corporate Strategy | 18 Feb 2022, 15:05 |
| /report/000089924322002870-brudnick-richard-2022-01-19 | Codiak BioSciences, Inc. | 19 Jan 2022 | 2 | $0 | 4 | Officer title: Chief Business Officer and Head of Corporate Strategy | 21 Jan 2022, 15:06 |